KRAS-driven lung adenocarcinoma: combined DDR1/Notch inhibition as an effective therapy
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference46 articles.
1. Non-small cell lung cancer, version 2.2013;Ettinger;J Natl Compr Canc Netw,2013
2. Epidemiology of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition);Alberg;Chest,2007
3. Malignant activation of a K-ras oncogene in lung carcinoma but not in normal tissue of the same patient;Santos;Science,1984
4. Prognostic and predictive value of K-RAS mutations in non-small cell lung cancer;Califano;Drugs,2012
5. Prognostic value of K-RAS mutations in patients with non-small cell lung cancer: a systematic review with meta-analysis;Meng;Lung Cancer,2013
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Biological and clinical significance of the glypican-3 gene in human lung adenocarcinoma: An in silico analysis;Medicine;2023-11-10
2. DDR1 functions as an immune negative factor in colorectal cancer by regulating tumor‐infiltrating T cells through IL ‐18;Cancer Science;2022-08-24
3. Adding predictive and diagnostic values of pulmonary ground-glass nodules on lung cancer via novel non-invasive tests;Frontiers in Medicine;2022-08-18
4. Identification and monitoring of mutations in circulating cell-free tumor DNA in hepatocellular carcinoma treated with lenvatinib;Journal of Experimental & Clinical Cancer Research;2021-06-26
5. The Journey of DDR1 and DDR2 Kinase Inhibitors as Rising Stars in the Fight Against Cancer;International Journal of Molecular Sciences;2021-06-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3